WebJan 31, 2024 · We identify a promising cytosine-based lead compound, Bobcat339, that has mid-μM inhibitor activity against TET1 and TET2, but does not inhibit the DNA … WebJan 16, 2024 · Description: Bobcat339 (Bobcat 339) is a novel cytosine-based TET enzyme inhibitor with IC50 of 33 uM (TET1) and 73 uM (TET2), but not DNMT3a, does not inhibit the DNA methyltransferase DNMT3a; Bobcat339 is a useful tool for investigation of epigenetics and serve as a starting point for new therapeutics that target DNA methylation and gene …
DNA Methyltransferase Activity DNA Methyltransferase Inhibitor …
WebBobcat339 hydrochloride C16H13Cl2N3O - PubChem Apologies, we are having some trouble retrieving data from our servers... PUGVIEW FETCH ERROR: 403 Forbidden … grey academia aesthetic
Oxygen regulation of TET enzymes - Matuleviciute - 2024 - FEBS …
WebBobcat339是一种选择性的基于胞嘧啶的TET enzyme抑制剂,对于TET1 和 TET2的IC50分别为33 μM和73 μM。 Bobcat339可通过抑制活细胞中的TET酶功能来降低DNA 5-羟甲基胞嘧啶的丰度,并为其实用的药理探针 … WebThe TET1 activity evaluation in the existence of Bobcat339 was also tested as the proof of concept of inhibitors screening. Our strategy provides a novel, label-free, and sensitive electrochemical approach that enables us to complete both TET1 activity evaluation and potential TET1 inhibitors screening. WebJan 6, 2024 · This underlines the current interest in developing targeted pharmaceutical inhibitors of these enzymes. Here, we will survey the complexity of TET roles in cancer, and its hypoxic modulation, as well as highlight the potential of these enzymes as therapeutic targets. Abbreviations α-KG α-ketoglutarate 5caC 5-carboxylcytosine 5fC 5-formylcytosine greyabbey presbyterian church